The expression of Notch1 and Notch4 and the target gene Hes1 and Hey2 decreased obviously, while the Notch2 and ERK pathway enhanced in patients with COPD, as well as in CSE-treated endothelial cells in vitro. This evidence concerns the gene HES1 and chronic obstructive pulmonary disease.